CONDENSED CONSOLIDATED STATEMENTS OF EQUITY - USD ($) shares in Thousands, $ in Millions		Total		Common Stock	Additional Paid-in Capital	Retained Earnings	AOCI Attributable to Parent	Treasury Stock	Non-controlling Interest
Beginning balance (in shares) at Dec. 31, 2018				290,000				14,000
Beginning balance at Dec. 31, 2018		$ 4,628		$ 0	$ 4,500	$ 641	$ (13)	$ (498)	$ (2)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options		6			6
Purchase of additional share in consolidated subsidiaries		(3)			4				(7)
Treasury stock repurchased (in shares)								(1,000)
Treasury stock repurchased		(46)						$ (46)
Change in reinsurance liabilities held at fair value resulting from a change in instrument-specific credit risk	[1]	0
Other comprehensive loss — unrealized gain on investments and other financial instruments		43					43
Other comprehensive earnings - unrealized gain on investments in unconsolidated affiliates		7	[2]				7
Other comprehensive earnings - unrealized gain on foreign currency translation		4	[3]				4
Reclassification adjustments for change in unrealized gains and losses included in net earnings		(5)	[4]				(5)
Stock-based compensation		18			18
Dividends declared, per common share		(171)				(171)
Subsidiary dividends declared to non-controlling interests		(5)							(5)
Net earnings		476				472			4
Ending balance (in shares) at Jun. 30, 2019				290,000				15,000
Ending balance at Jun. 30, 2019		4,952		$ 0	4,528	942	36	$ (544)	(10)
Beginning Balance at Dec. 31, 2018		344
Ending Balance at Jun. 30, 2019		344
Beginning balance (in shares) at Mar. 31, 2019				290,000				15,000
Beginning balance at Mar. 31, 2019		4,765		$ 0	4,510	762	14	$ (516)	(5)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options		5			5
Purchase of additional share in consolidated subsidiaries		(3)			4				(7)
Treasury stock repurchased		(28)						$ (28)
Change in reinsurance liabilities held at fair value resulting from a change in instrument-specific credit risk	[1]	0
Other comprehensive loss — unrealized gain on investments and other financial instruments		20					20
Other comprehensive earnings - unrealized gain on investments in unconsolidated affiliates		1	[2]				1
Other comprehensive earnings - unrealized gain on foreign currency translation		2	[3]				2
Reclassification adjustments for change in unrealized gains and losses included in net earnings		(1)	[4]				(1)
Stock-based compensation		9			9
Dividends declared, per common share		(86)				(86)
Subsidiary dividends declared to non-controlling interests		(2)							(2)
Net earnings		270				266			4
Ending balance (in shares) at Jun. 30, 2019				290,000				15,000
Ending balance at Jun. 30, 2019		4,952		$ 0	4,528	942	36	$ (544)	(10)
Beginning Balance at Mar. 31, 2019		344
Ending Balance at Jun. 30, 2019		344
Beginning balance (in shares) at Dec. 31, 2019				292,000				17,000
Beginning balance at Dec. 31, 2019		5,365		$ 0	4,581	1,356	43	$ (598)	(17)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options (in shares)				2,000
Exercise of stock options		37			37
F&G acquisition (in shares)				24,000				7,000
F&G acquisition		577			794			$ (217)
Treasury stock repurchased (in shares)								(3,000)
Treasury stock repurchased		(104)						$ (104)
Change in reinsurance liabilities held at fair value resulting from a change in instrument-specific credit risk		3	[1]				3
Other comprehensive loss — unrealized gain on investments and other financial instruments		380
Other comprehensive earnings - unrealized gain on investments in unconsolidated affiliates		7	[2]				7
Other comprehensive earnings - unrealized gain on foreign currency translation		(4)	[3]				(4)
Reclassification adjustments for change in unrealized gains and losses included in net earnings	[4]	0
Stock-based compensation		19			19		0
Dividends declared, per common share		(187)				(187)
Subsidiary dividends declared to non-controlling interests		(5)							(5)
Net earnings		261				248			13
Ending balance (in shares) at Jun. 30, 2020				318,000				27,000
Ending balance at Jun. 30, 2020		6,349		$ 0	5,431	1,417	429	$ (919)	(9)
Beginning Balance at Dec. 31, 2019		344
Ending Balance at Jun. 30, 2020		344
Beginning balance (in shares) at Mar. 31, 2020				292,000				20,000
Beginning balance at Mar. 31, 2020		5,116		$ 0	4,592	1,204	28	$ (692)	(16)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options (in shares)				2,000
Exercise of stock options		35			35
F&G acquisition (in shares)				24,000				7,000
F&G acquisition		577			794			$ (217)
Treasury stock repurchased		(10)						$ (10)
Change in reinsurance liabilities held at fair value resulting from a change in instrument-specific credit risk		3	[1]				3
Other comprehensive loss — unrealized gain on investments and other financial instruments		389					389
Other comprehensive earnings - unrealized gain on investments in unconsolidated affiliates	[2]	0
Other comprehensive earnings - unrealized gain on foreign currency translation		5	[3]				5
Reclassification adjustments for change in unrealized gains and losses included in net earnings		4	[4]				4
Stock-based compensation		10			10
Dividends declared, per common share		(96)				(96)
Subsidiary dividends declared to non-controlling interests		(2)							(2)
Net earnings		318				309			9
Ending balance (in shares) at Jun. 30, 2020				318,000				27,000
Ending balance at Jun. 30, 2020		6,349		$ 0	$ 5,431	$ 1,417	$ 429	$ (919)	$ (9)
Beginning Balance at Mar. 31, 2020		344
Ending Balance at Jun. 30, 2020		$ 344

[1] Net of income tax expense of $1 million for the three and six-month periods ended June 30, 2020.

[2] Net of income tax expense of $0 million and $1 million for the three-month periods ended June 30, 2020 and 2019, respectively, and $2 million and $2 million for the six-month periods ended June 30, 2020 and 2019, respectively.

[3] Net of income tax expense (benefit) of $2 million and $1 million for the three-month periods ended June 30, 2020 and 2019, respectively, and $(1) million and $1 million for the six-month periods ended June 30, 2020 and 2019, respectively.

[4] Net of income tax expense (benefit) of $1 million and $(1) million for the three-month periods ended June 30, 2020 and 2019, respectively, and $0 million and $(2) million for the six-month periods ended June 30, 2020 and 2019, respectively.(5)Net of income tax expense of $1 million for the three and six-month periods ended June 30, 2020.